Related Experiment Videos

[Anesthetic management of a patient with osteogenesis imperfecta congenita]

Y Masuda1, Y Harada, E Honma

  • 1Department of Anesthesiology, Sapporo Medical College and Hospital.

Masui. the Japanese Journal of Anesthesiology
|March 1, 1990
PubMed

Insights

Anesthetic management for osteogenesis imperfecta requires careful sedation and monitoring. Regional anesthesia is preferred due to risks of hyperthermia with inhaled agents like halothane and enflurane.

Area of Science:

  • Anesthesiology
  • Pediatric Anesthesia
  • Genetics

Background:

  • Osteogenesis imperfecta (OI) presents unique challenges in anesthetic management, particularly in pediatric patients.
  • The disease involves bone fragility and potential systemic complications affecting anesthesia choices.

Observation:

  • Three pediatric cases of OI undergoing surgical procedures are presented.
  • Case 1: A 2-year-old boy required intramuscular ketamine for induction after intrarectal chloral hydrate. Case 2: A 4-year-old girl experienced hyperthermia during halothane and enflurane anesthesia in two of three surgeries. Case 3: A 14-year-old female had successful anesthesia with a brachial plexus block.

Findings:

  • Preoperative sedation is crucial for managing patient anxiety in OI.
  • Inhaled anesthetic agents (halothane, enflurane) are associated with a risk of abnormal hyperthermia in OI patients.
  • Regional anesthesia, as demonstrated in Case 3, offers a safer alternative with no anesthetic complications.

Implications:

  • Anesthesiologists should exercise caution when using volatile anesthetics in patients with osteogenesis imperfecta.
  • Regional anesthesia techniques should be considered as a primary anesthetic modality for OI patients.
  • Further research into the specific mechanisms of hyperthermia in OI under anesthesia is warranted.

Related Concept Videos